Active Substance & Generic Molecule Directory

Marbofloxacin in Malaysia: Registered Brands, Dosages & Price Comparison

Directory of all approved pharmaceutical brands containing Marbofloxacin registered with the National Pharmaceutical Regulatory Agency (NPRA) / Ministry of Health Malaysia (KKM).

14
Registered Brands
Availability in Malaysia:
Showing 14 of 14 registered brands
MAL Reg NoBrand Formulation NameStrength / DosageClassificationRegistration HolderAction
MAL19056134HABoflox 100 mg/ml Solution For Injection100 mg 1 mlVeterinary (MAL-V)Yenher Agro-products Sdn. Bhd.Compare →
MAL23036032HACRBOFLOX FLAVOUR 20 mg TABLETS FOR DOGS AND CATS20 mgVeterinary (MAL-V)My Vet Care Sdn BhdCompare →
MAL19116013HAForcyl 160mg/ml Solution for Injection160 mg/mLVeterinary (MAL-V)Gladron Chemicals Sdn BhdCompare →
MAL20162584HAMarbocyl 10%W/V Solution For Injection100 mg In: 1 mlVeterinary (MAL-V)Gladron Chemicals Sdn BhdCompare →
MAL15010002HAMARBOCYL P TABLET 20MG20 mgVeterinary (MAL-V)Gladron Chemicals Sdn BhdCompare →
MAL12050018HAMARBOCYL P TABLET 5MG5 mgVeterinary (MAL-V)Gladron Chemicals Sdn BhdCompare →
MAL15010003HAMARBOCYL P TABLET 80MG80 mgVeterinary (MAL-V)Gladron Chemicals Sdn BhdCompare →
MAL19106032HAMarbovitryl 2%w/v Solution for Injection20 mg 1 mlVeterinary (MAL-V)Vemedim Sdn BhdCompare →
MAL24026025HAMarbovitryl FD 5 mg tablet5 mg 300 mgVeterinary (MAL-V)Vemedim Sdn BhdCompare →
MAL21076026HARMarbox 100 mg/ml Solution for Injection100 mg/mLVeterinary (MAL-V)Ceva Animal Health Malaysia Sdn. Bhd.Compare →
MAL24116047HAMARBOXA TAB 20 (Marbofloxacin 20mg Tablets)20.00 mgVeterinary (MAL-V)STADPHARM SDN. BHD.Compare →
MAL24116046HAMARBOXA TAB 80 (Marbofloxacin 80mg Tablets)80.00 mgVeterinary (MAL-V)STADPHARM SDN. BHD.Compare →
MAL22126065HAMARBOXIN 10% w/v INJECTION100 mg 1 mlVeterinary (MAL-V)RANGE PHARMA SDN. BHD.Compare →
MAL23076005HAMARBOXIN 2% w/v INJECTION20 mg 1 mlVeterinary (MAL-V)RANGE PHARMA SDN. BHD.Compare →

Generic Bioequivalence & Drug Substitution in Malaysia

Generic medications registered under NPRA contain the identical active pharmaceutical ingredient (API) in identical dosage strength and route of administration as the originator brand. NPRA requires rigorous bioequivalence (BE) studies demonstrating that generic drugs deliver the exact therapeutic effect. Always confirm with your doctor or community pharmacist before switching between prescription brands.